Further references, this time from a Pubmed search:
1: Neurosci Lett. 2003 Mar 20;339(2):99-102. Links
Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients.
2: Neurosci Lett. 2000 Feb 18;280(2):119-22. Links
Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.
3: Dement Geriatr Cogn Disord. 2006;21(3):131-8. Epub 2006 Jan 2. Links
CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival.
4: JAMA. 2003 Apr 23-30;289(16):2094-103. Links
Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.
words of warning...., page-9
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $12.53K | 4.143M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13926044 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 153031722 | 56 |
View Market Depth
| Last trade - 14.56pm 19/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |